These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31492371)

  • 1. Evaluation of Different Blood Circulating miRNAs for Hepatocellular Carcinoma Diagnosis.
    Wang S; Wu J; Shen S; Geng Z; Ling Y; Peng B
    J Nanosci Nanotechnol; 2020 Mar; 20(3):1983-1988. PubMed ID: 31492371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China.
    Jiang L; Cheng Q; Zhang BH; Zhang MZ
    Medicine (Baltimore); 2015 Mar; 94(10):e603. PubMed ID: 25761179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of miR-125b and miR-27a enhances sensitivity and specificity of AFP-based diagnosis of hepatocellular carcinoma.
    Zuo D; Chen L; Liu X; Wang X; Xi Q; Luo Y; Zhang N; Guo H
    Tumour Biol; 2016 May; 37(5):6539-49. PubMed ID: 26637228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis.
    Li G; Shen Q; Li C; Li D; Chen J; He M
    Clin Transl Oncol; 2015 Sep; 17(9):684-93. PubMed ID: 25956842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
    Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
    Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma.
    Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY
    Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-483-5p and miR-133a as Biomarkers for Diagnosis of Hepatocellular Carcinoma Post-Hepatitis C Infection in Egyptian Patients.
    Hassan AS; Elgendy NA; Tawfik NA; Elnasser AM
    Egypt J Immunol; 2019 Jul; 26(2):31-40. PubMed ID: 31926493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of serum microRNA-21 in diagnosis of hepatocellular carcinoma (HCC): clinical analyses of patients and an HCC rat model.
    Wang X; Zhang J; Zhou L; Lu P; Zheng ZG; Sun W; Wang JL; Yang XS; Li XL; Xia N; Zhang N; Dou KF
    Int J Clin Exp Pathol; 2015; 8(2):1466-78. PubMed ID: 25973032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus.
    Hung CH; Hu TH; Lu SN; Kuo FY; Chen CH; Wang JH; Huang CM; Lee CM; Lin CY; Yen YH; Chiu YC
    Int J Cancer; 2016 Feb; 138(3):714-20. PubMed ID: 26264553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma.
    Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z
    Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of serum exosomal microRNAs as diagnostic and prognostic biomarkers for hepatocellular carcinoma.
    Xue X; Zhao Y; Wang X; Qin L; Hu R
    J Cell Biochem; 2019 Jan; 120(1):135-142. PubMed ID: 30238497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.
    Chen L; Chu F; Cao Y; Shao J; Wang F
    Tumour Biol; 2015 Sep; 36(10):7439-47. PubMed ID: 25903466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.
    Shaker O; Alhelf M; Morcos G; Elsharkawy A
    Infect Genet Evol; 2017 Jul; 51():173-181. PubMed ID: 28366737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.